Monteiro L,
Barbieri C, Warnakulasuriya
S, Martins M, Salazar F, Pacheco JJ, Vescovi P, Meleti M.
Type of surgical treatment and recurrence of oral leukoplakia: A retrospective
clinical study. Med Oral Patol Oral
Cir Bucal. 2017 Sep 1;22
(5):e520-6.
doi:10.4317/medoral.21645
http://dx.doi.org/doi:10.4317/medoral.21645
1. Warnakulasuriya S, Johnson NW, van
der Waal I. Nomenclature
and classification of potentially
malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80. |
|
|
|
2. Petti S. Pooled
estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770-80. |
|
|
|
3. van der Waal I, Schepman
KP, van der Meij EH, Smeele
LE. Oral leukoplakia: a clinicopathological
review. Oral Oncol.
1997;33:291-301. |
|
|
|
4. van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal.
2014;19:e386-90. |
|
|
|
5. Maserejian NN, Joshipura
KJ, Rosner BA, Giovannucci
E, Zavras AI. Prospective
study of alcohol consumption
and risk of oral premalignant
lesions in men. Cancer Epidemiol Biomarkers Prev.
2006;15:774-81. |
|
|
|
6. Bagan JV, Jimenez
Y, Murillo J, Gavalda C, Poveda R, Scully C, et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus
infection. J Oral Maxillofac
Surg. 2007;65:46-9. |
|
|
|
7. Arduino PG, Bagan
J, El-Naggar AK, Carrozzo
M. Urban legends series:
oral leukoplakia. Oral Dis.
2013;19:642-59. |
|
|
|
8. Mehanna HM, Rattay
T, Smith J, McConkey CC. Treatment
and follow-up of oral dysplasia
- a systematic review and
meta-analysis. Head Neck.
2009;31:1600-9. |
|
|
|
9. Lodi G, Porter S. Management of potentially malignant disorders: evidence and
critique. J Oral Pathol Med.
2008;37:63-9. |
|
|
|
10. Ishii J, Fujita
K, Komori T. Laser surgery
as a treatment for oral leukoplakia. Oral Oncol.
2003;39:759-69. |
|
|
|
11. Lim B, Smith A, Chandu A. Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers:
a comparison. J Oral Maxillofac
Surg. 2010;68:597-601. |
|
|
|
12. van der Hem PS, Nauta JM, van der Wal JE, Roodenburg JL. The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol. 2005;41:31-7. |
|
|
|
13. Tewari M, Rai
P, Singh GB, Kumar M, Shukla
HS. Long-term follow-up results of Nd: YAG laser treatment
of premalignant and malignant
(Stage I) squamous cell carcinoma of the oral cavity. J Surg Oncol. 2007;95:281-5. |
|
|
|
14. Brouns ER, Baart
JA, Karagozoglu KH, Aartman
IH, Bloemena E, van der Waal
I. Treatment results of
CO2 laser vaporisation in a cohort
of 35 patients with oral leukoplakia. Oral Dis.
2013;19:212-6. |
|
|
|
15. Chandu A, Smith AC. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg.
2005;34:396-400. |
|
|
|
16. Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg.
2002;31:145-53. |
|
|
|
17. Jerjes W, Upile
T, Hamdoon Z, Al-Khawalde
M, Morcos M, Mosse CA, et
al. CO2 laser of oral dysplasia: clinicopathological features of
recurrence and malignant transformation. Lasers Med Sci. 2012;27:169-79. |
|
|
|
18. Gooris PJ, Roodenburg
JL, Vermey A, Nauta JM. Carbon
dioxide laser evaporation
of leukoplakia of the lower lip: a retrospective evaluation. Oral Oncol. 1999;35:490-5. |
|
|
|
19. Hamadah O, Thomson PJ. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study. Lasers Surg Med.
2009;41:17-25. |
|
|
|
20. Yang SW, Tsai CN, Lee YS, Chen TA. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the
factors affecting recurrence. J Oral Maxillofac Surg. 2011;69:e78-87. |
|
|
|
21. Chiesa F, Boracchi P, Tradati N, Rossi N, Costa L, Giardini R, et al. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncol.
1993;29B(1):23-8. |
|
|
|
22. Schoelch ML, Sekandari
N, Regezi JA, Silverman S
Jr. Laser management of oral leukoplakias:
a follow-up study of 70 patients. Laryngoscope.
1999;109:949-53. |
|
|
|
23. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially
malignant disorders among patients accrued over a 10-year period in South East England. J
Oral Pathol Med.
2011;40:677-83. |
|
|
|
24. Yang SW, Wu CJ, Lee YS, Chen TA, Tsai CN. Postoperative recurrence as an associated factor of malignant transformation of
oral dysplastic leukoplakia.
ORL J Otorhinolaryngol Relat
Spec. 2010;72:280-90. |
|
|
|
25. Lopez-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of oral leukoplakia with CO(2) laser and cold knife: a randomized clinical trial. Med Oral Patol
Oral Cir Bucal. 2013;18:e38-44. |
|
|
|
26. Del Corso G, Gissi DB, Tarsitano A, Costabile E, Marchetti C, Montebugnoli L, et
al. Laser evaporation versus laser excision of oral leukoplakia: A
retrospective study with long-term follow-up. J Craniomaxillofac Surg. 2015;43:763-8. |
|
|
|
27. Seoane J, Gonzalez-Mosquera
A, Lopez-Nino J, Garcia-Caballero
L, Aliste C, Seoane-Romero JM, et al. Er,Cr:YSGG laser therapy for oral leukoplakia minimizes thermal artifacts on surgical margins: a pilot study. Lasers Med Sci.
2013;28:1591-7. |
|
|
|
28. Vescovi P, Corcione
L, Meleti M, Merigo E, Fornaini C, Manfredi M, et al. Nd:YAG laser versus traditional
scalpel. A preliminary histological analysis of specimens from the human oral mucosa. Lasers Med Sci. 2010;25:685-91. |
|
|
|
29. Kuribayashi Y, Tsushima
F, Sato M, Morita K, Omura K. Recurrence
patterns of oral leukoplakia
after curative surgical resection: important factors that predict the risk of recurrence
and malignancy. J Oral Pathol
Med. 2012;41:682-8. |
|
|
|
30. Vescovi P, Manfredi
M, Merigo E, Fornaini C, Rocca JP, Nammour S, et al. Quantic molecular resonance scalpel and its potential applications in oral surgery. Br J Oral Maxillofac Surg. 2008;46:355-7. |